168 related articles for article (PubMed ID: 17072846)
1. Injectable hyaluronic acid microhydrogels for controlled release formulation of erythropoietin.
Hahn SK; Kim JS; Shimobouji T
J Biomed Mater Res A; 2007 Mar; 80(4):916-24. PubMed ID: 17072846
[TBL] [Abstract][Full Text] [Related]
2. Sustained release formulation of erythropoietin using hyaluronic acid hydrogels crosslinked by Michael addition.
Hahn SK; Oh EJ; Miyamoto H; Shimobouji T
Int J Pharm; 2006 Sep; 322(1-2):44-51. PubMed ID: 16781096
[TBL] [Abstract][Full Text] [Related]
3. Selectively crosslinked hyaluronic acid hydrogels for sustained release formulation of erythropoietin.
Motokawa K; Hahn SK; Nakamura T; Miyamoto H; Shimoboji T
J Biomed Mater Res A; 2006 Sep; 78(3):459-65. PubMed ID: 16721757
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and degradation test of hyaluronic acid hydrogels.
Hahn SK; Park JK; Tomimatsu T; Shimoboji T
Int J Biol Macromol; 2007 Mar; 40(4):374-80. PubMed ID: 17101173
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of hyaluronic acid-poly(ethylene glycol) hydrogels via Michael addition: An injectable biomaterial for cartilage repair.
Jin R; Moreira Teixeira LS; Krouwels A; Dijkstra PJ; van Blitterswijk CA; Karperien M; Feijen J
Acta Biomater; 2010 Jun; 6(6):1968-77. PubMed ID: 20025999
[TBL] [Abstract][Full Text] [Related]
6. An injectable hyaluronic acid-tyramine hydrogel system for protein delivery.
Lee F; Chung JE; Kurisawa M
J Control Release; 2009 Mar; 134(3):186-93. PubMed ID: 19121348
[TBL] [Abstract][Full Text] [Related]
7. Control of the molecular degradation of hyaluronic acid hydrogels for tissue augmentation.
Oh EJ; Kang SW; Kim BS; Jiang G; Cho IH; Hahn SK
J Biomed Mater Res A; 2008 Sep; 86(3):685-93. PubMed ID: 18022803
[TBL] [Abstract][Full Text] [Related]
8. Hybrid hyaluronan hydrogel encapsulating nanogel as a protein nanocarrier: new system for sustained delivery of protein with a chaperone-like function.
Hirakura T; Yasugi K; Nemoto T; Sato M; Shimoboji T; Aso Y; Morimoto N; Akiyoshi K
J Control Release; 2010 Mar; 142(3):483-9. PubMed ID: 19951730
[TBL] [Abstract][Full Text] [Related]
9. The self-crosslinking smart hyaluronic acid hydrogels as injectable three-dimensional scaffolds for cells culture.
Bian S; He M; Sui J; Cai H; Sun Y; Liang J; Fan Y; Zhang X
Colloids Surf B Biointerfaces; 2016 Apr; 140():392-402. PubMed ID: 26780252
[TBL] [Abstract][Full Text] [Related]
10. Facile synthesis and characterization of disulfide-cross-linked hyaluronic acid hydrogels for protein delivery and cell encapsulation.
Choh SY; Cross D; Wang C
Biomacromolecules; 2011 Apr; 12(4):1126-36. PubMed ID: 21384907
[TBL] [Abstract][Full Text] [Related]
11. Injectable hyaluronic acid-tyramine hydrogels for the treatment of rheumatoid arthritis.
Kim KS; Park SJ; Yang JA; Jeon JH; Bhang SH; Kim BS; Hahn SK
Acta Biomater; 2011 Feb; 7(2):666-74. PubMed ID: 20883838
[TBL] [Abstract][Full Text] [Related]
12. Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells.
Kim J; Kim IS; Cho TH; Lee KB; Hwang SJ; Tae G; Noh I; Lee SH; Park Y; Sun K
Biomaterials; 2007 Apr; 28(10):1830-7. PubMed ID: 17208295
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
14. Synthesis by AGET ATRP of degradable nanogel precursors for in situ formation of nanostructured hyaluronic acid hydrogel.
Bencherif SA; Washburn NR; Matyjaszewski K
Biomacromolecules; 2009 Sep; 10(9):2499-507. PubMed ID: 19711888
[TBL] [Abstract][Full Text] [Related]
15. Bone reservoir: Injectable hyaluronic acid hydrogel for minimal invasive bone augmentation.
MartÃnez-Sanz E; Ossipov DA; Hilborn J; Larsson S; Jonsson KB; Varghese OP
J Control Release; 2011 Jun; 152(2):232-40. PubMed ID: 21315118
[TBL] [Abstract][Full Text] [Related]
16. Functionalization of hyaluronic acid with chemoselective groups via a disulfide-based protection strategy for in situ formation of mechanically stable hydrogels.
Ossipov DA; Piskounova S; Varghese OP; Hilborn J
Biomacromolecules; 2010 Sep; 11(9):2247-54. PubMed ID: 20704177
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering.
Shu XZ; Ahmad S; Liu Y; Prestwich GD
J Biomed Mater Res A; 2006 Dec; 79(4):902-12. PubMed ID: 16941590
[TBL] [Abstract][Full Text] [Related]
18. Physical entrapment of hyaluronic acid during synthesis results in extended release from model hydrogel and silicone hydrogel contact lens materials.
Weeks A; Subbaraman LN; Jones L; Sheardown H
Eye Contact Lens; 2013 Mar; 39(2):179-85. PubMed ID: 23411992
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin.
Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP
J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659
[TBL] [Abstract][Full Text] [Related]
20. Effects of cross-linking molecular weights in a hyaluronic acid-poly(ethylene oxide) hydrogel network on its properties.
Noh I; Kim GW; Choi YJ; Kim MS; Park Y; Lee KB; Kim IS; Hwang SJ; Tae G
Biomed Mater; 2006 Sep; 1(3):116-23. PubMed ID: 18458391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
